Multilayer Olanzapine Tablet With Barrier Layer for Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Antipsychotic medications, particularly atypical antipsychotics like olanzapine, are associated with significant weight gain and metabolic issues, necessitating the development of more effective formulations that minimize weight gain while maintaining therapeutic efficacy.
Innovation Solution
The development of multi-layer tablets, such as bi-layer tablets, that contain olanzapine and samidorphan, which are chemically incompatible, but are formulated to provide a substantially immediate release profile and minimize impurity formation, using a barrier layer to maintain physical distance and include pharmaceutically acceptable excipients for stability and release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If olanzapine and samidorphan are formulated together in a single tablet, then weight gain associated with olanzapine can be reduced, but chemical incompatibility between the two substances leads to impurity formation and stability issues
Solution Approach 1:
The tablet is divided into multiple layers (e.g., first layer containing olanzapine, second layer containing samidorphan) to physically separate chemically incompatible substances. This segmentation prevents direct chemical interaction and impurity formation while allowing both drugs to be administered together in a single unit dose, maintaining the therapeutic benefit of reduced weight gain.
Solution Approach 2:
A barrier layer or coating is introduced between olanzapine and samidorphan layers to act as an intermediary that prevents direct chemical contact. This intermediate layer maintains chemical stability by blocking interaction pathways while still allowing the tablet to function as a unified dosage form for simultaneous administration.
2Stability of the object's composition
If a barrier layer is introduced to maintain physical distance between incompatible substances, then chemical stability is improved, but device complexity increases
Solution Approach 1:
Multiple functional components (drug layers, barrier layers, excipients) are merged into a single integrated tablet structure. The barrier layer is combined with the drug-containing layers to form a unified multi-layer tablet that maintains chemical stability while presenting as a single administrable unit, thus managing complexity through integration rather than separation.
Solution Approach 2:
Thin film barrier layers are used to separate incompatible substances. These thin films provide effective chemical isolation while minimizing the addition of bulk and structural complexity. The flexible thin film approach allows the barrier function to be incorporated seamlessly into the tablet architecture without significantly increasing device complexity.
3Stability of the object's composition
If multi-layer formulation is used to separate incompatible substances, then chemical stability is improved, but manufacturing precision requirements increase
Solution Approach 1:
Manufacturing parameters such as compression force, layer thickness, and material composition are optimized to achieve consistent layer formation. By controlling these parameters within specified ranges, the formulation achieves reliable layer uniformity and chemical stability without requiring excessive manufacturing precision, making the process robust and scalable.
Data Source
AI summary
Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.